Fever Tracking Study

Fever Tracking Study: The Feasibility of Fever Tracking in a Home-setting by a Non-invasive Wearable Core Body Temperature Sensor

NCT05475067•University Hospital, Basel, Switzerland

View on ClinicalTrials.gov

Summary

The aim of this study is to investigate the feasibility of continuous fever tracking of participants having fever symptoms in a home setting, using a core body temperature (CBT) sensor. CBT as measured by the wearable sensors will be coampared with CBT as measured by ingestible electronc pills (reference). A secondary research question is, if the CBT behavior of the the participants in a home setting can be compared to previously described CBT profiles in the literature, and if special patterns can be identified.

Eligibility

Age

18 - 60 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Age 18-60 years old
•Informed consent signed
•Either:
•Acute fever symptoms at inclusion (at least 38.0°C) and Test for COVID-19 at the day of inclusion
•\- Or: Second shot or booster of mRNA COVD-19 vaccination (Comirnaty® or COVID-19 Vaccine Moderna®) at day of inclusion

Exclusion Criteria

•Any participant who, for any reason, is unable to independently consent to participate in the study and/or who is unable to independently follow the study protocol.
•Any participant with previous surgical procedures in the gastrointestinal tract
•Inability to swallow pills
•Any participant of ≤40 kg body weight
•A scheduled MRI examination in the period from the start of the measurements until seven days after ingestion of the electronic pill.
•Any participant being pregnant
•Impairment or disability of the upper extremity likely to have a negative impact on the quality of measurements:
•* Wounds
•* Active venous access
•* Amputations
+7 more criteria

Locations (1)

Universitiy Hospital Basel

Basel, Canton of Basel-City, Switzerland

Key Dates

Start Date

October 7, 2021

Primary Completion Date

March 3, 2022

Completion Date

March 5, 2022

Last Updated

July 26, 2022

Enrollment

ACTUAL participants

Conditions

Core Body Temperature in Healthy SubjectsImmune Response to mRNA COVID-19 Vaccination